These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

597 related items for PubMed ID: 9822381

  • 1. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli.
    Mulvey MA, Lopez-Boado YS, Wilson CL, Roth R, Parks WC, Heuser J, Hultgren SJ.
    Science; 1998 Nov 20; 282(5393):1494-7. PubMed ID: 9822381
    [Abstract] [Full Text] [Related]

  • 2. Uropathogenic Escherichia coli induces extrinsic and intrinsic cascades to initiate urothelial apoptosis.
    Klumpp DJ, Rycyk MT, Chen MC, Thumbikat P, Sengupta S, Schaeffer AJ.
    Infect Immun; 2006 Sep 20; 74(9):5106-13. PubMed ID: 16926402
    [Abstract] [Full Text] [Related]

  • 3. Intracellular bacterial biofilm-like pods in urinary tract infections.
    Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ.
    Science; 2003 Jul 04; 301(5629):105-7. PubMed ID: 12843396
    [Abstract] [Full Text] [Related]

  • 4. Differentiation-induced uroplakin III expression promotes urothelial cell death in response to uropathogenic E. coli.
    Thumbikat P, Berry RE, Schaeffer AJ, Klumpp DJ.
    Microbes Infect; 2009 Jan 04; 11(1):57-65. PubMed ID: 19007907
    [Abstract] [Full Text] [Related]

  • 5. Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli.
    Eto DS, Jones TA, Sundsbak JL, Mulvey MA.
    PLoS Pathog; 2007 Jul 04; 3(7):e100. PubMed ID: 17630833
    [Abstract] [Full Text] [Related]

  • 6. Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding.
    Zhou G, Mo WJ, Sebbel P, Min G, Neubert TA, Glockshuber R, Wu XR, Sun TT, Kong XP.
    J Cell Sci; 2001 Nov 04; 114(Pt 22):4095-103. PubMed ID: 11739641
    [Abstract] [Full Text] [Related]

  • 7. Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses.
    Mulvey MA, Schilling JD, Martinez JJ, Hultgren SJ.
    Proc Natl Acad Sci U S A; 2000 Aug 01; 97(16):8829-35. PubMed ID: 10922042
    [Abstract] [Full Text] [Related]

  • 8. Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism.
    Schilling JD, Mulvey MA, Vincent CD, Lorenz RG, Hultgren SJ.
    J Immunol; 2001 Jan 15; 166(2):1148-55. PubMed ID: 11145696
    [Abstract] [Full Text] [Related]

  • 9. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection.
    Mulvey MA, Schilling JD, Hultgren SJ.
    Infect Immun; 2001 Jul 15; 69(7):4572-9. PubMed ID: 11402001
    [Abstract] [Full Text] [Related]

  • 10. Requirement of Rho-family GTPases in the invasion of Type 1-piliated uropathogenic Escherichia coli.
    Martinez JJ, Hultgren SJ.
    Cell Microbiol; 2002 Jan 15; 4(1):19-28. PubMed ID: 11856170
    [Abstract] [Full Text] [Related]

  • 11. Type 1, P and S fimbriae, and afimbrial adhesin I are not essential for uropathogenic Escherichia coli to adhere to and invade bladder epithelial cells.
    Miyazaki J, Ba-Thein W, Kumao T, Obata Yasuoka M, Akaza H, Hayshi H.
    FEMS Immunol Med Microbiol; 2002 Mar 25; 33(1):23-6. PubMed ID: 11985964
    [Abstract] [Full Text] [Related]

  • 12. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination.
    Langermann S, Palaszynski S, Barnhart M, Auguste G, Pinkner JS, Burlein J, Barren P, Koenig S, Leath S, Jones CH, Hultgren SJ.
    Science; 1997 Apr 25; 276(5312):607-11. PubMed ID: 9110982
    [Abstract] [Full Text] [Related]

  • 13. Surfactant protein D inhibits adherence of uropathogenic Escherichia coli to the bladder epithelial cells and the bacterium-induced cytotoxicity: a possible function in urinary tract.
    Kurimura Y, Nishitani C, Ariki S, Saito A, Hasegawa Y, Takahashi M, Hashimoto J, Takahashi S, Tsukamoto T, Kuroki Y.
    J Biol Chem; 2012 Nov 16; 287(47):39578-88. PubMed ID: 23012359
    [Abstract] [Full Text] [Related]

  • 14. In vitro binding of type 1-fimbriated Escherichia coli to uroplakins Ia and Ib: relation to urinary tract infections.
    Wu XR, Sun TT, Medina JJ.
    Proc Natl Acad Sci U S A; 1996 Sep 03; 93(18):9630-5. PubMed ID: 8790381
    [Abstract] [Full Text] [Related]

  • 15. Uropathogenic escherichia coli: interactions with bladder epithelium.
    Hultgren SJ.
    Urology; 2001 Jun 03; 57(6 Suppl 1):105-6. PubMed ID: 11378067
    [No Abstract] [Full Text] [Related]

  • 16. Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic Escherichia coli.
    Mysorekar IU, Mulvey MA, Hultgren SJ, Gordon JI.
    J Biol Chem; 2002 Mar 01; 277(9):7412-9. PubMed ID: 11744708
    [Abstract] [Full Text] [Related]

  • 17. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells.
    Martinez JJ, Mulvey MA, Schilling JD, Pinkner JS, Hultgren SJ.
    EMBO J; 2000 Jun 15; 19(12):2803-12. PubMed ID: 10856226
    [Abstract] [Full Text] [Related]

  • 18. Cathelicidin augments epithelial receptivity and pathogenesis in experimental Escherichia coli cystitis.
    Danka ES, Hunstad DA.
    J Infect Dis; 2015 Apr 01; 211(7):1164-73. PubMed ID: 25336727
    [Abstract] [Full Text] [Related]

  • 19. Microbiology. Pods invade infected bladders.
    Ferber D.
    Science; 2003 Jul 04; 301(5629):31. PubMed ID: 12843366
    [No Abstract] [Full Text] [Related]

  • 20. Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli.
    Hultgren SJ, Porter TN, Schaeffer AJ, Duncan JL.
    Infect Immun; 1985 Nov 04; 50(2):370-7. PubMed ID: 2865209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.